| 000 | 01928 a2200565 4500 | ||
|---|---|---|---|
| 005 | 20250517174722.0 | ||
| 264 | 0 | _c20180302 | |
| 008 | 201803s 0 0 eng d | ||
| 022 | _a1569-8041 | ||
| 024 | 7 |
_a10.1093/annonc/mdx404 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLeduc, C | |
| 245 | 0 | 0 |
_aClinical and molecular characteristics of non-small-cell lung cancer (NSCLC) harboring EGFR mutation: results of the nationwide French Cooperative Thoracic Intergroup (IFCT) program. _h[electronic resource] |
| 260 |
_bAnnals of oncology : official journal of the European Society for Medical Oncology _cNov 2017 |
||
| 300 |
_a2715-2724 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aBiomarkers, Tumor _xgenetics |
| 650 | 0 | 4 |
_aCarcinoma, Non-Small-Cell Lung _xdrug therapy |
| 650 | 0 | 4 |
_aErbB Receptors _xantagonists & inhibitors |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aFrance |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLung Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aMutation |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 |
_aProtein Kinase Inhibitors _xtherapeutic use |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aSurvival Rate |
| 700 | 1 | _aMerlio, J P | |
| 700 | 1 | _aBesse, B | |
| 700 | 1 | _aBlons, H | |
| 700 | 1 | _aDebieuvre, D | |
| 700 | 1 | _aBringuier, P P | |
| 700 | 1 | _aMonnet, I | |
| 700 | 1 | _aRouquette, I | |
| 700 | 1 | _aFraboulet-Moreau, S | |
| 700 | 1 | _aLemoine, A | |
| 700 | 1 | _aPouessel, D | |
| 700 | 1 | _aMosser, J | |
| 700 | 1 | _aVaylet, F | |
| 700 | 1 | _aLanglais, A | |
| 700 | 1 | _aMissy, P | |
| 700 | 1 | _aMorin, F | |
| 700 | 1 | _aMoro-Sibilot, D | |
| 700 | 1 | _aCadranel, J | |
| 700 | 1 | _aBarlesi, F | |
| 700 | 1 | _aBeau-Faller, M | |
| 773 | 0 |
_tAnnals of oncology : official journal of the European Society for Medical Oncology _gvol. 28 _gno. 11 _gp. 2715-2724 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1093/annonc/mdx404 _zAvailable from publisher's website |
| 999 |
_c27600074 _d27600074 |
||